The Battle Continues over Merck’s “Super Aspirin” Vioxx, Years after the Drug’s Withdrawal

The 2004 withdrawal of Vioxx from the worldwide market was by no means the end of the Vioxx saga. As evidence of Vioxx’s prothrombotic (heart attack-causing) effects became public, experts examined and re-examined every moment in the life of the drug. What they uncovered was a shocking series of events that allowed a drug, which the FDA estimates may have caused more than 27,000 deaths, to reach an uninformed public.

As Merck struggles to preserve its public image and regain the trust of consumers, it seems that an endless string of damning information comes to light. As recently as April 2008, nearly four years after the Vioxx ban, a new investigation uncovered even more evidence that Merck was aware of the cardiovascular risks of Vioxx from the time of the drug’s inception.

If you or a loved one has taken Vioxx, it is incumbent upon you to stay informed. Unfortunately, the elevated risk of heart attack and stroke may not subside once you have stopped taking the drug. The Vioxx Advisor is a safe place to sort through the muddled media frenzy surrounding Vioxx.

Please read the following areas of The Vioxx Advisor for easy-to-understand information about Vioxx:

• Basic Vioxx Information
• Uses of Vioxx
• How Vioxx Works
• Vioxx Lawsuits
• Vioxx Side Effects
• Vioxx Risk Factors